Description
The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual’s DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a person’s genome. Because most known mutations that cause disease occur in exons, whole exome sequencing is thought to be an efficient method to identify possible disease-causing mutations.
Exome Sequencing Market provides the following data:
- Exome Sequencing Market, 2019-2024
- Exome Sequencing Market by Region, 2019 (%; US, Europe, ROW)
Table of Contents
1: Executive Summary
Demand for Effectiveness
Selected Products on the Market
-
- Table 1-1: Selected Exome Sequencing Kits
Challenges, Possible Disruption in the Market
WGS/WES Comparison
-
- Figure 1-1: Cost per Human Genome, 2001 to 2019 ñ NIH
Size and Growth of the Market
Exome Sequencing Recent Developments
2: Exome Sequencing Market
Products on the Market
-
- Table 2-1: Sequencers Used In Exome Sequencing
Application Forecast of Exome Sequencing: End Users
-
- Figure 2-1: Applications Expected to Increase the Most, 2019
-
- Table 2-2: Applications Expected to Increase the Most ñ Change between 2017 and 2019
Size and Growth of the Market
-
- Figure 2-2: Exome Sequencing Market, 2019-2024
- Regional Market
- Figure 2-3: Exome Sequencing Market by Region, 2019 (%; US, Europe, ROW)
3: Company Profiles
10X Genomics
Agilent Technologies
BGI Genomics (formerly Beijing Genome Institute)
Illumina
Oxford Nanopore
Qiagen N.V.
Roche Diagnostics
Thermo Fisher Scientific Inc.
